Large Addressable Markets with High Unmet Needs
Efti’s three late-stage oncology programs: Lung, Head and Neck, and Breast Cancer
Non-small cell lung cancer (NSCLC)
drug market to nearly double to
$48 billion in 20312
Metastatic breast cancer (MBC)
market to reach $12.7 billion by 20246
Head and neck squamous cell carcinoma
(HNSCC) market projected to reach $3.5
billion by 2025
The above from the presso...
Two crucial aspects.....1... .EFTI has to work
2 .....Then what percentage of the addressable market will EFTI combos or EFTI itself address...
There's big money involved here if EFTI keeps ticking boxes...
- Forums
- ASX - By Stock
- IMM
- Ann: Immutep Corporate Presentation
Ann: Immutep Corporate Presentation, page-4
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $537.4M |
Open | High | Low | Value | Volume |
37.0¢ | 38.3¢ | 36.5¢ | $1.060M | 2.841M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 48648 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 13814 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 36000 | 0.365 |
4 | 139181 | 0.360 |
2 | 9450 | 0.355 |
7 | 161310 | 0.350 |
2 | 10769 | 0.345 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 5000 | 1 |
0.375 | 133425 | 3 |
0.380 | 64650 | 3 |
0.385 | 53062 | 4 |
0.390 | 197301 | 5 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online